The antitumor effects of bacterial lipopolysaccharides (LPSs) have been the subject of research for almost a century (6, 23) . Transplantable syngeneic tumors growing intradermally or subcutaneously can be completely cured with a single but sometimes lethal injection of LPS at a distant site (20) . This effect was quite dramatic. Within 6 to 8 h of the LPS injection, erythema developed at the tumor site. By 24 h, extensive hemorrhagic necrosis was evident, and by 48 to 72 h most of the tumor mass had been sloughed (2) .
Recently, Carswell et al. discovered that the tumor necrotic action of LPS was not a direct effect of LPS on tumor cells but rather was mediated by a factor present in sera of LPStreated animals (5) . A similar factor could be isolated from sera of LPS-treated mice and rabbits without tumors but previously injected with Mycobacterium bovis strain BCG (10, 14) . The tumor necrosis activity of serum from LPStreated animals could be separated from many of the toxic effects of LPS itself (10) . Moreover, although tumor cells of different origins were inhibited or killed by this tumor necrosis factor in vitro, normal embryonic fibroblasts were unaffected under the same conditions (5, 11, 19) .
Based on these earlier observations, we have developed a sensitive and quantitative in vitro assay for cytotoxic factors in the sera of LPStreated animals. In a previous communication we used this assay to discriminate the cytotoxic factor from lymphocyte-activating factor which appears in BCG-infected mice after LPS injection (13) . In this report, conditions for optimal release of cytotoxic factors in sera of BCG-infected mice and physicochemical characterization of the active factor are presented.
MATERIALS AND METHODS Mice. Female C3H/HeN mice, 6 to 12 weeks of age, were obtained from the Division of Research Services, National Institutes of Health. C3H/HeJ mice were purchased from the Jackson Laboratory, Bar Harbor, Maine.
LPS. Escherichia coli K235 LPS was prepared by the phenol-water extraction method of McIntire et al. (16) or by the butanol extraction procedure described by Morrison (17) . Salmonella Minnesota Re mutant R595 LPS isolated by phenol-chloroform-petroleum ether method (8) was a generous gift of E. T. Rietschel, MPI, Freiburg, West Germany. Polysaccharide of S.
Minnesota (Freeman type [7] ) was kindly given by C. A 0.5-ml amount of unfractionated BCG-LPS serum was applied to a 5-mm-thick bed of Sephadex G75 Superfine with 5% Pharmalyte (Pharmacia) (pH 4 to 6.5) and focused for 18 h at a constant power of 1 W on a flatbed apparatus (LKB 2117 Multiphor). The fractions were eluted with 6 ml of phosphate-buffered saline. After we measured the pH of individual fractions, we dialyzed the fractions against phosphatebuffered saline for 24 h, sterilized them by filtration, and assayed them for tumor cytotoxicity.
Induction of tumors and in vitro culture of tumor cells. Fibrosarcomas were induced intradermally in mice with 1 mg of 3-methylcholanthrene in 0.2 ml of trioctanoin (tricaprylin, Sigma Chemical Co., St. Louis, Mo.). For in vitro culture, solid tumor pieces were minced and a single cell suspension was obtained by enzymatic digestion (3) . The cells were cultured in EMEM containing 10% FCS and 50,g of gentamicin per ml.
Generation of chimeric mice. Bone marrow cells were obtained by gently grinding and then rinsing femura and tibiae of donor mice in cold RPMI medium (GIBCO Laboratories, Grand Island, N.Y.). Bone fragments were removed by being allowed to settle for 5 min; the cells were washed and then suspended in medium to a concentration of 10" cells/ml. Cell viability exceeded 90% as determined by exclusion of trypan blue dye. Mice received 850 roentgens of X-irradiation and were reconstituted within 6 h by tail vein injection of 107 bone marrow cells. Three days before and for 2 weeks after reconstitution, the mice were given drinking water containing 1 g each of ampicillin (Totacillin-N, Beecham Laboratories, Bristol, Tenn.), carbenicillin (Pyophen, Beecham Laboratories), and cephalothin (Keflin, Eli Lilly & Co., Indianapolis, Ind.) per liter. Four to 6 weeks after reconstitution, the mice were used in the experiments.
RESULTS
In vitro detection of cytotoxic factors in serum of BCG-infected mice treated with LPS. Serum of BCG-infected mice treated with LPS (BCG-LPS serum) contained factors cytotoxic for tumor cells in vitro (Table 1) . Cytotoxicity was detected with each of 10 different murine fibrosarcomas after treatment with 1/100 dilution of BCG-LPS serum. The same dilution of serum had little or no effect on syngeneic embryo fibroblasts. It is important to note that fibrosarcomas from lipid A-unresponsive C3H/ HeJ mice were as susceptible to the active serum as fibrosarcomas from normally responsive C3H/HeN mice. (Fig. 1) . Significant cytotoxicity to L 929 cells by BCG-LPS/sera could be detected with as little as a 1/1,000 dilution. Cytotoxic activity, however, even at the higher serum concentration, was dependent on continuous presence of the cytotoxic factor (Fig. 2) . Target cells incubated with a 1/100 dilution of active serum for up to 8 mice. In addition, lipid A-unresponsive C3H/ HeJ mice failed to produce serum cytotoxic factors after the BCG-LPS treatment. C3H/HeJ mice treated with BCG and butanol-extracted LPS also failed to produce serum cytotoxic activity. Butanol-extracted LPS is a strong B cell mitogen even for the lipid A-unresponsive C3H/ HeJ mouse (9) . C3H/HeJ mice could produce cytotoxic factors only after adoptive transfer of lipid A-responsive C3H/HeN bone marrow ( (Table 4) . Although production of tumor cytotoxic activity in the serum of LPS-treated nude mice is at variance with an earlier observation by Old (18) , a recent report by Berendt et al. showed strong LPS-induced tumor-necrotizing effects in T celldeficient mice (4) .
Biochemical characterization of the tumor cytotoxic activity from serum. Tumor cytotoxic activity was as follows. (i) Cytotoxic activity was stable at 570C for more than 1 h, and no significant loss in activity was observed when samples were lyophilized or stored in solution at 40C for several weeks. (ii) BCG-LPS and control sera were applied to Sephacryl S-200 columns and eluted with Tris buffer containing 0.1 M sodium chloride. The elution profile showed one major peak; cytotoxic activity was found at an apparent molecular weight of 150,000. Control serum fractions had little or no cytotoxic activity. Most of the cytotoxic activity in serum was found in the precipitate of a 40 to 60% saturated ammonium sulfate solution. The ammonium sulfate precipitate was chromatographed as described above (Fig. 6A) . Again, major cytotoxic activity was found in the immunoglobulin G range; however, a second peak with an apparent molecular weight of about 55,000 to 60,000 was also detected. Fractions of LPS-induced control serum were inactive. Rechromatography ofthe same ammonium sulfate- INFECT. IMMUN. I precipitated material on an identical column but with a buffer of higher sodium chloride content (1.6 M) shifted the elution of cytotoxic activity to a single peak at 55,000 to 60,000 (Fig. 6B) . In a previous study, we reported these dissociating conditions in more detail, and the effect has been used to separate lymphocyte-activating factor from cytotoxic activity (13) .
(iii) Tumor cytotoxic serum or control serum was applied to diethylaminoethyl-Sephacel columns and washed with Tris buffer (pH 7.1). A gradient was started from 0 to 0.4 M sodium chloride. Cytotoxic activity in BCG-LPS serum eluted from the column at a 0.17 to 0.2 M sodium chloride concentration (Fig. 7) . eluted as a single peak at an apparent molecular weight of 55,000 to 60,000.
(iv) A 0.5-ml amount of unfractionated BCG-LPS serum was subjected to flatbed electrofocusing in a pH gradient from 4 to 6.5. Cytotoxic activity was recovered from the fraction eluates in a single peak together with serum albumin at about pH 4.8 (Fig. 8) ; yield was less than 5% of that applied, explanable in part by the instability of activity below pH 6 (data not shown).
DISCUSSION
Discovery of soluble mediators in sera of BCG-infected mice treated with microgram quantities of LPS that reproduced tumor necrotic actions of milligram quantities of LPS in noninfected animals was an important advance in the analysis of the antitumor properties of bacterial endotoxin (5) .
Characterization of these soluble mediators (tumor necrosis factors) promised the opportunity of separating, for the first time, the therapeutic action of LPS from the toxic and often lethal side effects. Fulfillment of this promise, however, was impeded by a difficult and imprecise in vivo assay.
Serum-induced necrosis of an intradermal tumor transplant required large volumes of active serum (0.5 ml per mouse), and the extent of the tumor necrosis endpoint was dependent upon location, size, and vascularization of the tumor (18) .
We have described in this report a sensitive and quantitative in vitro assay to detect cytotoxic mediators in sera of LPS-treated, BCG- (i) The time course for optimal production of tumor necrosis factor and for cytotoxic serum activity (intervals between BCG infection and LPS treatment and between LPS treatment and serum collection) was identical (5) .
(ii) Production of tumor necrosis factor and cytotoxic serum activity were both dependent upon normal LPS responsiveness; LPS-insensitive C3H/HeJ mice or X-irradiated LPS-sensitive C3H/HeN chimeric mice reconstituted with C3H/HeJ bone marrow failed to produce either activity after LPS challenge (13a).
(iii) The in vivo tumor necrotic action of LPS was evident in mice homozygous for the nu gene (data not shown); serum from LPS-treated, BCG-infected nude mice was also cytotoxic to tumor target cells in vitro.
(iv) Physicochemical characterization of mouse tumor necrosis factor reveals a heat-stable activity with an apparent molecular weight of 150,000 (10) . A recent report of a similar tumor necrotic factor of rabbit origin, however, described activity with an apparent molecular weight of about 50,000 (14) . This conflict in apparent molecular weight of mouse and rabbit tumor necrosis factor(s) could be explained by species differences. Our results, however, suggest an alternative explanation; mouse tumor necrosis factor may exist as an aggregate in serum.
Cytotoxic activity of active serum, as previously described by Carswell et al. (10) , eluted from Sephacryl S-200 in the 125,000 to 150,000 molecular weight region. Ammonium sulfate precipitation of this same serum followed by gel filtration in high ionic strength buffer of the precipitate (conditions favoring separation of aggregates) led to elution of cytotoxic activity at 55,000 to 60,000 daltons.
Several investigators have suggested that the cellular source of tumor necrosis factor may be the macrophage. Indeed, soluble cytotoxic factors have been isolated from macrophage cultures after a variety of in vitro treatments (1, 12, 21, 24) . Matthews described a soluble cytotoxic factor from rabbit monocytes which resembled the rabbit serum-derived tumor necrosis factor (15) . Preliminary results from our laboratory confirm and extend this observation. Macrophages from BCG-infected mice treated in vitro with LPS release soluble cytotoxic factors within 2 h of treatment. Physicochemical characteristics of this macrophage-derived cytotoxin were very similar to those of the serum factor described in this report. Cytotoxic factors were not detected in fluids of LPS-treated control macrophage cultures. These results suggest that the LPS-induced release of this cytotoxin may depend upon the level of macrophage activation. Recent observations by Russel and co-workers indicate that macrophages within growing tumors are either activated or can be activated with very small quantities of LPS (22) . The tumor necrotic action of LPS could certainly be mediated by soluble factors released by these intratumor-activated macrophages.
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